Guru Ownership Trend
Guru Analysis for iShares Biotechnology ETF (IBB)
iShares Biotechnology ETF (IBB), a key player in the Market sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $57.66 M.
Top institutional holders include Jefferies Group and Joel Greenblatt.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $837,462.91 net outflow during the quarter.
Recent activity highlights Joel Greenblatt who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 76.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for iShares Biotechnology ETF (IBB)
Major holders include Jefferies Group ($51.04 M), Joel Greenblatt ($3.82 M), Cliff Asness ($1.39 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 341,635 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $837,462.91, with 3 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited IBB. The total reported sell value was $5.01 M.
Yes, 1 managers opened new positions in IBB, and 2 increased their existing holdings. The total reported buy value was $4.17 M.